These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37867428)

  • 21. Vaccination status of COVID-19 patients followed up in the ICU in a country with heterologous vaccination policy: A multicenter national study in Turkey.
    Yıldırım S; Erkoyun E; Alpdoğan Ö; Yılmaz HO; Yılmaz B; Erdal Dönmez G; Sarıtaş A; Gökmen N; Ergan B; Bayrak V; Yakar MN; Kılıç Ö; Kılınç A; Saygılı S; Gaygısız Ü; Aydın K; Özel Yeşilyurt A; Cankar Dal H; Bayındır Dicle Ç; Turan S; Binay S; Yarıcı M; Yıldırım F; Hancı P; İnal MT; Akbaş T; Eyüpoğlu S; Albayrak T; Koçak G; Çakır T; Yüksel RC; Sarı A; Güneş M; Menteş O; Yamanel HL; Kirakli C
    J Infect Chemother; 2023 Oct; 29(10):959-964. PubMed ID: 37343924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories: A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System.
    Semenzato L; Botton J; Baricault B; Deloumeaux J; Joachim C; Sylvestre E; Dray-Spira R; Weill A; Zureik M
    PLoS One; 2022; 17(9):e0274309. PubMed ID: 36084113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of unvaccinated and vaccinated critically ill COVID-19 patients in calabria region (Italy): A retrospective study.
    Bruni A; Longhini F; Macheda S; Biamonte E; Pasqua P; Neri G; Guzzo ML; Garofalo E;
    Front Med (Lausanne); 2022; 9():1042411. PubMed ID: 36507545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of vaccination on ICU admissions of hospitalized COVID-19 patients in a country with a heterologous vaccine policy.
    Yıldırım S; Kirakli C; Özdemir Y; Tosun S; Ermin S; Polat G; Yılmaz C; Bilaçeroğlu S; Salık B; Kömürcüoğlu B; Ödemiş İ; Köse Ş; Uzun U; Aydın G; İlhan E
    J Infect Dev Ctries; 2024 Apr; 18(4):513-519. PubMed ID: 38728641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac].
    Özyurda F; Ardıçoğlu Akışın Y; Mert T; Poyraz B; Özkan Y; Turan M; Göçmen JS; Yücel A; Akar N
    Mikrobiyol Bul; 2022 Jul; 56(3):387-403. PubMed ID: 35960233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
    Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID-19 in the Omicron variant era: A national cohort study in Iran.
    Jamaati H; Karimi S; Ghorbani F; Panahi Y; Hosseini-Baharanchi FS; Hajimoradi M; Malek R; Noorali S; Mokhtari M; Khoundabi B; Sadr M; Mohamadnia A; Zahraei SM; Hashemian SM; Dastan F; Mortaz E; Tayeri K; Behtaj F; Vaezi H; Forouzanfar MM; Shafaghi S
    J Med Virol; 2023 Mar; 95(3):e28607. PubMed ID: 36815507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Vaccination with Pfizer-BioNTech or CoronaVac on Disease Prognosis Among Hospitalized COVID-19 Patients.
    Güldan M; Ateş ST; Sarıoğlu S; Suyabatmaz S; İrkören P; Tekin S; Kapmaz M; Keske Ş; Ergönül Ö
    Infect Dis Clin Microbiol; 2023 Jun; 5(2):106-112. PubMed ID: 38633010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reductions in stillbirths and preterm birth in COVID-19-vaccinated women: a multicenter cohort study of vaccination uptake and perinatal outcomes.
    Hui L; Marzan MB; Rolnik DL; Potenza S; Pritchard N; Said JM; Palmer KR; Whitehead CL; Sheehan PM; Ford J; Mol BW; Walker SP
    Am J Obstet Gynecol; 2023 May; 228(5):585.e1-585.e16. PubMed ID: 36336084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
    Wu Z; Hu Y; Xu M; Chen Z; Yang W; Jiang Z; Li M; Jin H; Cui G; Chen P; Wang L; Zhao G; Ding Y; Zhao Y; Yin W
    Lancet Infect Dis; 2021 Jun; 21(6):803-812. PubMed ID: 33548194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity.
    Kara Z; Akçin R; Demir AN; Dinç HÖ; Taşkın HE; Kocazeybek B; Yumuk VD
    Obes Surg; 2022 Sep; 32(9):2987-2993. PubMed ID: 35802279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients.
    Demir E; Dheir H; Safak S; Serra Artan A; Sipahi S; Turkmen A
    Vaccine; 2022 May; 40(24):3313-3319. PubMed ID: 35504784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
    J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 After Vaccination in Lung Transplant Recipients: Real-Life Data.
    Türkkan S; Çelik Başaran F; Şahin MF; Beyoğlu MA; Yılmaz E; Yazıcıoğlu A; Yiğit Özay H; Bindal M; Tezer Tekçe Y; Yekeler E
    Exp Clin Transplant; 2023 Mar; 21(3):265-271. PubMed ID: 35867010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative Analyses of IgA Antibody Response of Non-COVID-19 Infected People Over 60 Years Old Following CoronaVac and Pfizer-BioNTech COVID-19 Vaccination].
    Yürüker Ö; Yetkin O; Güvenir M
    Mikrobiyol Bul; 2023 Apr; 57(2):330-333. PubMed ID: 37067217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial.
    Zhang Y; Ma X; Yan G; Wu Y; Chen Y; Zhou Z; Wan N; Su W; Liu FW; Dai MX; Yang M; Li C; Yu X; Zhang L; Wang Z; Zhou TC; You D; Wei J; Zhang Z;
    EClinicalMedicine; 2022 Dec; 54():101680. PubMed ID: 36188435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series.
    Giacobbe DR; Labate L; Tutino S; Baldi F; Russo C; Robba C; Ball L; Dettori S; Marchese A; Dentone C; Magnasco L; Crea F; Willison E; Briano F; Battaglini D; Patroniti N; Brunetti I; Pelosi P; Bassetti M
    Ann Med; 2021 Dec; 53(1):1779-1786. PubMed ID: 34637370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study.
    Xie J; Wu W; Li S; Hu Y; Hu M; Li J; Yang Y; Huang T; Zheng K; Wang Y; Kang H; Huang Y; Jiang L; Zhang W; Zhong M; Sang L; Zheng X; Pan C; Zheng R; Li X; Tong Z; Qiu H; Du B
    Intensive Care Med; 2020 Oct; 46(10):1863-1872. PubMed ID: 32816098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].
    Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P
    Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.